{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:40:43Z","timestamp":1790386843884,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Psychiatry"],"published-print":{"date-parts":[[2008]]},"DOI":"10.4103\/0019-5545.39761","type":"journal-article","created":{"date-parts":[[2009,9,15]],"date-time":"2009-09-15T02:55:36Z","timestamp":1252983336000},"page":"54","source":"Crossref","is-referenced-by-count":8,"title":["Hyperprolactinaemia with amisulpride"],"prefix":"10.4103","volume":"50","author":[{"given":"Rajnish","family":"Raj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BalwantSingh","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-5545.39761-1","unstructured":"Matthysse SW. The role of dopamine in schizophrenia. In : Usdin E, Hamburg DA, Barchas J, editors. Neuroregulators and psychiatric disorders. Oxford University Press: New York; 1977."},{"key":"key-10.4103\/0019-5545.39761-2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0165-6147(94)90323-9","article-title":"Dopamine receptor pharmacology","author":"Seeman","year":"1994","journal-title":"Trends Pharmacol Sci"},{"key":"key-10.4103\/0019-5545.39761-3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from dopamine D2 receptor explain the action of atypical antipsychotics.A new hypothesis?","author":"Kapur","year":"2001","journal-title":"Am J Psychiatry"},{"key":"key-10.4103\/0019-5545.39761-4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.156.2.286","article-title":"Clinical and theoretical implications of 5 HT 2 and D 2 receptor occupancy of clozapine, risperidone and olanzapine in schizophrenia","author":"Kapur","year":"1999","journal-title":"Am J Psychiatry"},{"key":"key-10.4103\/0019-5545.39761-5","first-page":"S19","article-title":"Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia","author":"Kasper","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"key":"key-10.4103\/0019-5545.39761-6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3565(24)36395-5","article-title":"Neurochemical characteristics of amisulpride, an atypical dopamine D2\/D3 receptor antagonist with both presynaptic and limbic selectivity","author":"Schoemaker","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.4103\/0019-5545.39761-7","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/00004850-199705002-00006","article-title":"Amisulpride: From animal pharmacology to therapeutic action","author":"Scatton","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"key":"key-10.4103\/0019-5545.39761-8","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.pnpbp.2003.09.006","article-title":"Amisulpride: Limbic specificity and the mechanism of antipsychotic atypicality","author":"Moller","year":"2003","journal-title":"Prog Neuropsychopharmacol Bio Psychiatry"},{"key":"key-10.4103\/0019-5545.39761-9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02245616","article-title":"In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia","author":"Martinot","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"key-10.4103\/0019-5545.39761-10","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0920-9964(98)00158-3","article-title":"Prolactin and antipsychotic medications: Mechanism of action","author":"Petty,","year":"1999","journal-title":"Schizophr Res"},{"key":"key-10.4103\/0019-5545.39761-11","first-page":"S97","article-title":"Prolactin levels and symptoms of hyperprolactinaemia in patients treated with amisulpride, risperidone, olanzapine and quetiapine","author":"Fric","year":"2003","journal-title":"Psychiatr Prax"},{"key":"key-10.4103\/0019-5545.39761-12","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1176\/appi.ajp.159.7.1249-a","article-title":"The beef with atypical antipsychotics","author":"Sauer","year":"2002","journal-title":"Am J Psychiatry"},{"key":"key-10.4103\/0019-5545.39761-13","first-page":"10","article-title":"Hormonal side effects in women: Typical versus atypical antipsychotic treatment","author":"Dickson","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"key-10.4103\/0019-5545.39761-14","doi-asserted-by":"crossref","unstructured":"Wilson, CA. Pharmacological targets for the control of male and female sexual behaviour. In : Sexual Pharmacology. Rilley AJ, Peet M, Wilson C, editor. Oxford Medical Publications: Oxford; 1993. p. 1-58.","DOI":"10.1093\/oso\/9780192622839.003.0001"},{"key":"key-10.4103\/0019-5545.39761-15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1192\/bjp.181.1.49","article-title":"Sexual dysfunction in patients taking conventional antipsychotic medication","author":"Smith","year":"2002","journal-title":"Br J Psychiatry"},{"key":"key-10.4103\/0019-5545.39761-16","first-page":"S1","article-title":"From pharmacological profiles to clinical outcomes","author":"Kerwin","year":"2000","journal-title":"Int Clin Psychopharmcol"},{"key":"key-10.4103\/0019-5545.39761-17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0022-3956(94)90004-3","article-title":"Acute antagonism of dopamine D2 receptors by amisulpride: Effects on hormone secretion in healthy volunteers","author":"Wetzel","year":"1994","journal-title":"J Psychiatr Res"},{"key":"key-10.4103\/0019-5545.39761-18","unstructured":"Kopecek M, Bares M, Svarc J, et al . Hyperprolactinaemia after low dose of amisulpride [abstract no. P01. 186]. 24 th Congress of the Collegium Internationale Neuro-Psychopharmacologicam: Paris; 2004. Jun 20-24."},{"key":"key-10.4103\/0019-5545.39761-19","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic- induced hyperprolactinaemia mechanism, clinical features and management","author":"Haddad","year":"2004","journal-title":"Drugs"},{"key":"key-10.4103\/0019-5545.39761-20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1192\/pb.19.12.755","article-title":"Treatment of psychotrophic-induced hyperprolactinaemia","author":"Duncan","year":"1995","journal-title":"Psychiatr Bull"},{"key":"key-10.4103\/0019-5545.39761-21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2165\/00023210-199810030-00005","article-title":"Hyperprolactinaemia in antipsychotic treated patients: Guidelines for avoidance and management","author":"Hammer","year":"1998","journal-title":"CNS Drugs"},{"key":"key-10.4103\/0019-5545.39761-22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4088\/JCP.v65n0207","article-title":"Cabergoline treatment of risperidone-induced hyperprolactinemia: A pilot study","author":"Cavallaro","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"key-10.4103\/0019-5545.39761-23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1192\/bjp.185.2.147","article-title":"Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2FNx01A1 allele","author":"Young","year":"2004","journal-title":"Br J Psychiatry"}],"container-title":["Indian Journal of Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:00:04Z","timestamp":1787065204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0019-5545.39761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"alternative-id":["39761"],"URL":"https:\/\/doi.org\/10.4103\/0019-5545.39761","relation":{},"ISSN":["0019-5545"],"issn-type":[{"value":"0019-5545","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}